Positive Trial Results of Pulmaquin Reported for Non-CF Bronchiectasis Patients with Chronic Lung Infections
Bronchiectasis, News
Aradigm reported positive results from the ORBIT-3 (NCT01515007 ) and ORBIT-4 (NCT02104245) Phase 3 clinical trials assessing Pulmaquin for the treatment of non-cystic fibrosis bronchiectasis (non-CF BE) in patients with chronic lung infection by Pseudomonas aeruginosa bacteria. The pivotal clinical trials ... Read more